𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)

✍ Scribed by Garrido, P.; Thatcher, N.; Crino, L.; Dansin, E.; Laskin, J.; Pavlakis, N.; Tsai, C.M.; Reck, M.; Schneider, C.P.; Griesinger, F.


Book ID
123530414
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
48 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


PCN14 AN INDIRECT COMPARISON OF THE EFFI